Age profile of immunity to influenza: Effect of original antigenic sin

Theoretical Population Biology

Volumn 81, Issue 2, 2012, Pages 102-112

  Kucharski, Adam J ^a   Gog, Julia R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Age structure; Cross immunity; Epidemic; Influenza; Multi strain model; Original antigenic sin

Indexed keywords

ANTIGEN; INFLUENZA VACCINE;

AGE STRUCTURE; ANTIGEN; EPIDEMIC; IMMUNITY; INFECTIVITY; INFLUENZA; NUMERICAL MODEL; POPULATION DYNAMICS;

ADAPTIVE IMMUNITY; AGE; ARTICLE; BIOLOGICAL MODEL; DISEASE TRANSMISSION; EPIDEMIOLOGY; HEALTH; HUMAN; IMMUNOLOGY; INFLUENZA; MUTATION; POPULATION DYNAMICS; THEORETICAL MODEL;

ADAPTIVE IMMUNITY; AGE FACTORS; ANTIGENS; EPIDEMIOLOGIC METHODS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, GENETIC; MODELS, THEORETICAL; MUTATION; POPULATION DYNAMICS; WORLD HEALTH;

EID: 84856531057     PISSN: 00405809     EISSN: 10960325     Source Type: Journal    
DOI: 10.1016/j.tpb.2011.12.006     Document Type: Article

References (45)

1. Adalja A., Henderson D. Original antigenic sin and pandemic (H1N1) 2009. Emerg. Infect. Dis. 2010, 16(6):1028. 10.3201/eid1606.091563.
2. Adams B., Sasaki A. Antigenic distance and cross-immunity, invasibility and coexistence of pathogen strains in an epidemiological model with discrete antigenic space. Theor. Popul. Biol. 2009, 76(3):157-167. 10.1016/j.tpb.2009.06.001.
3. Anderson R.M., May R.M. Infectious Diseases of Humans, Dynamics and Control 1991, Oxford University Press.
4. Andreasen V. Dynamics of annual influenza A epidemics with immuno-selection. J. Math. Biol. 2003, 46:504-536. 10.1007/s00285-002-0186-2.
5. Andreasen V., Lin J., Levin S.A. The dynamics of cocirculating influenza strains conferring partial cross-immunity. J. Math. Biol. 1997, 35:825-842. 10.1007/s002850050079.
6. Andreasen V., Sasaki A. Shaping the phylogenetic tree of influenza by cross-immunity. Theor. Popul. Biol. 2006, 70:164-173. 10.1016/j.tpb.2006.04.004.
7. Boni M.F. Vaccination and antigenic drift in influenza. Vaccine 2008, 26S:C8-C14. 10.1016/j.vaccine.2008.04.011.
8. Bullo F., Cortes J., Martinez S. Distributed Control of Robotic Networks 2009, Princeton University Press.
9. Bush R., Fitch W., Bender C., Cox N. Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol. Biol. Evol. 1999, 16(11):1457.
10. Castillo-Chavez C., Hethcote H.W., Andreasen V., Levin S.A., Liu W.M. Epidemiological models with age structure, proportionate mixing, and cross-immunity. J. Math. Biol. 1989, 27:233-258.
11. Doolan D.L., Dobaño C., Baird J.K. Acquired immunity to malaria. Clin. Microbiol. Rev. 2009, 22(1):13-36. Table of Contents. 10.1128/CMR.00025-08.
12. Ferguson, N., Andreasen, V., 2002. The influence of different forms of cross-protective immunity on the population dynamics of antigenically diverse pathogens, Mathematical approaches for emerging and reemerging infectious diseases: models, methods, and theory, pp. 157.
13. Ferguson N.M., Galvani A.P., Bush R.M. Ecological and immunological determinants of influenza evolution. Nature 2003, 422:428-433. 10.1038/nature01509.
14. Francis T. On the doctrine of original antigenic sin. Proc. Am. Phil. Soc. 1960, 104(6):572-578.
15. Gog J.R., Grenfell B.T. Dynamics and selection of many-strain pathogens. Proc. Natl. Acad. Sci. 2002, 99(26):17209-17214. 10.1073/pnas.252512799.
16. Gog J.R., Swinton J. A status-based approach to multiple strain dynamics. J. Math. Biol. 2002, 44:169-184. 10.1007/s002850100120.
17. Gomes M.G.M., Medley G.F., Nokes D.J. On the determinants of population structure in antigenically diverse pathogens. Proc. R. Soc. B 2002, 269:227-233. 10.1098/rspb.2001.1869.
18. Gupta S., Ferguson N., Anderson R. Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science 1998, 280(5365):912-915. 10.1126/science.280.5365.912.
19. Hanski I. Metapopulation dynamics. Nature 1998, 396(6706):41-49.
20. Hughes A. Evolutionary change of predicted cytotoxic T cell epitopes of dengue virus. Infect. Genet. Evol. 2001, 1(2):123-130. 10.1016/S1567-1348(01)00013-2.
21. Ikonen N., et al. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Eurosurveillance 2010, 15(5).
22. Kim J., Skountzou I., Compans R., Jacob J. Original antigenic sin responses to influenza viruses. J. Immunol. 2009, 183(5):3294. 10.4049/jimmunol.0900398.
23. Koelle K., Cobey S., Grenfell B.T., Pascual M. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 2006, 314:1898-1903. 10.1126/science.1132745.
24. Kryazhimskiy S., Dieckmann U., Levin S., Dushoff J. On state-space reduction in multi-strain pathogen models, with an application to antigenic drift in influenza A. PLoS Comput. Biol. 2007, 3(8). 10.1371/journal.pcbi.0030159.eor.
25. Lambert P.-H., Liu M., Siegrist C.-A. Can successful vaccines teach us how to induce efficient protective immune responses?. Nat. Med. 2005, 11(Suppl. 4):S54-S62. 10.1038/nm1216.
26. Lavenu A., Leruez-Ville M., Chaix M., Boelle P., Rogez S., Freymuth F., Hay A., Rouzioux C., Carrat F. Detailed analysis of the genetic evolution of influenza virus during the course of an epidemic. Epidemiol. Infect. 2005, 134(03):514-520. 10.1017/S0950268805005686.
27. Miller E., Hoschler K., Hardelid P., Stanford E., Andrews N., Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010, 10.1016/S0140-6736(09)62126-7.
28. Minayev P., Ferguson N.M. Improving the realism of deterministic multi-strain models: implications for modelling influenza A. J. R. Soc. Interface 2008, 6(35):509-518. 10.1098/rsif.2008.0333.
29. Morens D., Burke D., Halstead S. The wages of original antigenic sin. Emerg. Infect. Dis. 2010, 16(6):1023-1024. 10.3201/eid1606.100453.
30. Ndifon W., Wingreen N., Levin S. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proc. Natl. Acad. Sci. 2009, 106(21):8701. 10.1073/pnas.0903427106.
31. Nelson M.I., Edelman L., Spiro D.J., Boyne A.R., Bera J., Halpin R., Sengamalay N., Ghedin E., Miller M.A., Simonsen L., Viboud C., Holmes E.C. Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. PLoS Pathog. 2008, 4(8):e1000133. 10.1371/journal.ppat.1000133.
32. Office for National Statistics, 2007. National Statistics Online. Directgov.
33. Rambaut A., Pybus O.G., Nelson M.I., Viboud C., Taubenberger J.K., Holmes E.C. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008, 453:615-619. 10.1038/nature06945.
34. Ramirez B., Simon-Loriere E., Galetto R., Negroni M. Implications of recombination for HIV diversity. Virus Res. 2008, 134(1-2):64-73. http://j.virusres.2008.01.007.
35. Recker M., Pybus O., Nee S., Gupta S. The generation of influenza outbreaks by a network of host immune responses against a limited set of antigenic types. Proc. Natl. Acad. Sci. 2007, 104(18):7711. 10.1073/pnas.0702154104.
36. Tillett H., Nicholas S., Watson J. Unusual pattern of influenza mortaliy in 1989-1990. Lancet 1991, 338(8782-8783):1590-1591. 10.1016/0140-6736(91)92408-T.
37. Tria F., Lässig M., Peliti L., Franz S. A minimal stochastic model for influenza evolution. J. Stat. Mech. 2005, 10.1088/1742-5468/2005/07/P07008.
38. US Department of Heath Update: influenza activity-United States, 1999-2000 season. Morb. Mortal. Wkly. Rep. 2000, 49(9):173-177.
39. Viboud C., Tam T., Fleming D., Miller M., Simonsen L. 1951 influenza epidemic, England and Wales, Canada, and the United States. Emerg. Infect. Dis. 2006, 12(4):661-668.
40. Virelizier J., Postlethwaite R., Schild G., Allison A. Antibody responses to antigenic determinants of influenza virus hemagglutinin. J. Exp. Med. 1974, 140(6):1559.
41. Webster R, Kasel J., Couch R., Laver W. Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. J. Infecct. Dis. 1976, 134(1):48-58.
42. Wilson I., Cox N. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 1990, 8(1):737-787.
43. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.-Y., Mays I., Garman L., Helms C., James J., Air G.M., Capra J.D., Ahmed R., Wilson P.C. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453(7195):667-671. 10.1038/nature06890.
44. Yewdell J. Viva la revolución: rethinking influenza A virus antigenic drift. Curr. Opin. Virol. 2011.
45. Zimmer S.M., Crevar C.J., Carter D.M., Stark J.H., Giles B.M., Zimmerman R.K., Ostroff S.M., Lee B.Y., Burke D.S., Ross T.M. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One 2010, 5(7):e11601. 10.1371/journal.pone.0011601.